文献速递前列腺癌

并非所有多参数磁共振成像靶向活检都相同:活检方式类型与操作者经验对临床显著性前列腺癌检出率的影响

Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.
PubMed 文献 · Eur Urol Oncol · 2018-05-15

研究纳入2013至2016年单中心244例同期接受12针经直肠超声活检与mpMRI靶向活检(认知活检或融合活检)的患者,比较不同靶向方式检出临床显著性前列腺癌(csPCa)的差异及操作者经验的作用。结果显示融合活检靶向样本csPCa检出率57%高于认知活检36%(p=0.002),多因素分析中融合活检与操作者经验均与更高检出概率相关(OR分别为2.4和1.7,均p≤0.03)。

要点

  • 融合活检靶向样本csPCa检出率57% vs 认知活检36%(p=0.002)。
  • 多因素分析中融合活检与操作者经验与更高csPCa检出概率相关(OR 2.4和1.7,均p≤0.03)。
  • 仅融合活检患者中操作者经验仍为独立预测因子(OR 1.9,p=0.004)。

核心结论

  • 融合活检对csPCa的检出率高于认知活检,且操作者经验与更高的csPCa检出率显著相关。

研究设计与样本

  • 单中心连续纳入244例患者,2013至2016年同期接受12针经直肠超声活检与mpMRI靶向活检(认知活检或融合活检)。
  • 所有患者接受1.5-T mpMRI(直肠内线圈),靶向PI-RADS v.2评分≥3的病灶,活检由三名操作者作为其首批靶向活检病例完成。
  • 采用多因素逻辑回归分析评估活检方式(融合活检 vs 认知活检)与操作者经验对csPCa检出的关联。

主要发现

  • 总体csPCa检出率融合活检58% vs 认知活检45%(p=0.07)。
  • 靶向样本csPCa检出率融合活检57% vs 认知活检36%(p=0.002)。
  • 多因素分析中融合活检与操作者经验均与靶向样本csPCa检出概率升高相关(OR 2.4和1.7,均p≤0.03)。
  • 仅融合活检患者中操作者经验仍为csPCa检出的独立预测因子(OR 1.9,p=0.004)。
  • 校正所有混杂因素后,随操作例数增加csPCa检出概率升高。

关键数值与推荐

  • csPCa定义为活检Gleason评分≥7。
  • 靶向病灶为mpMRI PI-RADS v.2评分≥3。
  • 操作者经验编码为每位医师完成的靶向活检累计例数。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The extensive use of multiparametric magnetic resonance imaging (mpMRI) has led to an even more widespread use of different targeted biopsy techniques and approaches. The best way of performing targeted biopsies and the effect of operator expertise have still to be defined. OBJECTIVE: To compare the rate of detection of clinically significant prostate cancer (csPCa) of different mpMRI targeted approaches and to assess the role of operator expertise in the detection of csPCa. DESIGN, SETTING, AND PARTICIPANTS: We included 244 consecutive patients who underwent both 12-core transrectal ultrasound (TRUS) biopsy and mpMRI targeted biopsy with either a cognitive biopsy (CB) or fusion biopsy (FB) approach during the same session between 2013 and 2016 at a single tertiary referral centre. INTERVENTION: All men underwent 1.5-T mpMRI with an endorectal coil. All biopsies were performed by three operators as their first cases of targeted biopsy. Lesions with a Prostate Imaging Recording and Data System (PI-RADS) v.2 score of ≥3 detected at mpMRI were targeted. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: csPCa was defined as disease with a Gleason score at biopsy of ≥7. Operator expertise was coded as the progressive number of targeted biopsies performed by each physician. Multivariable logistic regression analyses (MVA) were used to assess the association between the targeted biopsy technique (FB vs CB) and operator expertise for detection of csPCa. Covariates consisted of prostate-specific antigen, prostate volume, PI-RADS v.2 (3 vs >3), number of targeted cores per MRI lesion, and digital rectal examination (negative vs positive). The same analyses were performed for patients undergoing FB only after accounting for the FB approach (transrectal vs transperineal). A lowess smoothing weighted function was used to graphically assess the effect of operator expertise on the probability of detecting csPCa, after accounting for all confounders. RESULTS AND LIMITATIONS: Overall, 157 patients (64%) underwent FB and 87 (36%) underwent CB. The overall csPCa detection rate was 58% for FB and 45% for CB (p=0.07). A significantly higher rate of csPCa detection in targeted samples was observed for FB compared to CB (57% vs 36%; p=0.002). On MVA, FB and operator expertise were significantly associated with a higher probability of csPCa detection in targeted samples (odds ratio [OR] 2.4 and 1.7, respectively; both p≤0.03). When the same analyses were repeated for patients undergoing FB, operator expertise remained an independent predictor of csPCa detection (OR 1.9; p=0.004). An increase in the probability of detecting csPCa with the number of procedures performed was observed after accounting for all confounders. CONCLUSIONS: We demonstrated that FB had higher detection rate than CB for csPCa. Moreover, operator expertise was significantly associated with higher detection rates for csPCa. PATIENT SUMMARY: When different targeted biopsy techniques were compared, fusion biopsy provided a higher detection rate compared to cognitive biopsy for clinically significant prostate cancer (csPCa). Moreover, we found that operator expertise was an important predictor of the detection of csPCa, regardless of the procedure used.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Stabile A, Dell'Oglio P, Gandaglia G, et al. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer. Eur Urol Oncol. 2018. PMID: 31100235. doi:10.1016/j.euo.2018.02.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。